MED
Medifast Inc

1,789
Mkt Cap
$129.92M
Volume
136,355.00
52W High
$16.66
52W Low
$10.10
PE Ratio
557.89
MED Fundamentals
Price
$11.66
Prev Close
$11.82
Open
$11.72
50D MA
$11.29
Beta
0.68
Avg. Volume
292,973.95
EPS (Annual)
$0.1907
P/B
0.60
Rev/Employee
$1.2M
Loading...
Loading...
News
all
press releases
The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings
The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings The Compliance Imperative: Regulatory Moats Driving 2026 Asset Re-Ratings PR Newswire VANCOUVER, BC, Jan. 19, 2026 ISSUED ON...
PR Newswire·1d ago
News Placeholder
More News
News Placeholder
People Magazine Spotlights Tiffany Howards Metabolic Health Journey with OPTAVIA
Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, celebrates the inspiring health transformation of Tiffany Howard, recently...
Business Wire·5d ago
News Placeholder
OPTAVIA Premieres Second Docuseries Episode Health by Design: Spain Exploring Metabolic Health and Longevity
Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, premiered its newest docuseries episode, Health by Design: Spain, which...
Business Wire·6d ago
News Placeholder
Hims & Hers Expands Platform-Led Access to Provider-Directed Care
HIMS broadens access to provider-led care with new offerings in diagnostics, hormonal health and at-home testing.
Zacks·8d ago
News Placeholder
Medifast Shifts to Metabolic Health: A Durable Growth Path?
MED is pivoting to metabolic health, using clinical data and new products to address root causes beyond GLP-1 weight loss.
Zacks·12d ago
News Placeholder
Medifast Announces Planned Leadership Transition
Medifast, Inc. (NYSE: MED) today announced a planned leadership transition designed to provide continuity and stability as the company continues its evolution toward metabolic health. Medifast...
Business Wire·16d ago
News Placeholder
Medifast New Product Line Planned: Can Innovation Reignite Demand?
MED plans a new product line rooted in metabolic synchronization science, upgrading its core offerings as it shifts beyond weight loss.
Zacks·21d ago
News Placeholder
Medifast's Third-Quarter Revenue Fell 36%: Is Stabilization Near?
MED witnesses revenue plunge as its coach base shrank, but restructuring and productivity initiatives aim to stabilize results by late 2025.
Zacks·27d ago
News Placeholder
Hims & Hers Expands Subscription-Led Care as Platform Engagement Grows
HIMS deepens its subscription-led model with new care verticals, diagnostics and global expansion to boost retention.
Zacks·28d ago
News Placeholder
Can Medifast Overcome GLP-1 Pressure With Its Growth Strategy?
MED targets long-term metabolic health with programs that preserve muscle and support lasting wellness amid GLP-1 adoption.
Zacks·1mo ago
<
1
2
...
>

Latest MED News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.